Overview
Ametropia is the first cause of reversible visual trouble. Recently, laser refractive surgery has increased in popularity. Unfortunately, dry eye is a common side effect, representing about 25% of patients after LASIK and 20% after SMILE. Even if symptoms are usually released by artificial tears, there can be very uncomfortable for patients, decrease productivity and quality of life and be the source of unsatisfaction after surgery.
The goal of our study is to study the efficiency of a preventive associated treatment by intense-pulsed-light and low-level-light therapy with EYE-LIGHT® device before laser refractive surgery. Recent study confirmed the efficacity of this treatment in meibomian glund dysfunction, the predominant dry eye mecanism.
Description
monocentric, randomized, simple bling, controlled study
Eligibility
Inclusion Criteria:
- ametropia without progression for almost one year
- pachymetry >480 um
- myopia < -8 dioptre
- hyperopia < +6 dioptre
- astigmatism < -5 dioptre
Exclusion Criteria:
- other ocular disease (such as keratoconus, cataract, glaucoma, AMD, diabetic retinopathy, etc.)
- infectious or systemic pathology (e.g.: epilepsia, migraine)
- pregnancy, fitzpatrick V or VI (eye-light contraindication)